Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ... May 14
Approval is for ERBITUX in combination with platinum-based therapy with fluorouracil for the first-line treatment of Head and Neck cancer... Mar 03
New subgroup analyses for first-line treatment of advanced renal cell carcinoma with BAVENCIO®* (avelumab) in combination with axitinib... Sep 23
-Advertisements-